Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, DC, USA.
Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC, USA.
BJOG. 2016 Oct;123(11):1797-803. doi: 10.1111/1471-0528.13817. Epub 2015 Dec 8.
To estimate the incidence and risk of complications associated with a fetal scalp electrode and to determine whether its application in the setting of operative vaginal delivery was associated with increased neonatal morbidity.
Retrospective cohort study.
Twelve clinical centers with 19 hospitals across nine American Congress of Obstetricians and Gynecologists US districts.
Women in the USA.
We evaluated 171 698 women with singleton deliveries ≥ 23 weeks of gestation in a secondary analysis of the Consortium on Safe Labor study between 2002 and 2008, after excluding conditions that precluded fetal scalp electrode application such as prelabour caesarean delivery. Secondary analysis limited to operative vaginal deliveries ≥ 34 weeks of gestation was also performed.
Incidences and adjusted odds ratios with 95% confidence intervals of neonatal complications were calculated, controlling for maternal characteristics, delivery mode and pregnancy complications.
Fetal scalp electrode was used in 37 492 (22%) of deliveries. In non-operative vaginal delivery, fetal scalp electrode was associated with increased risk of injury to scalp due to birth trauma (1.2% versus 0.9%; adjusted odds ratios 1.62; 95% confidence intervals 1.41-1.86) and cephalohaematoma (1.0% versus 0.9%; adjusted odds ratios 1.57; 95% confidence intervals 1.36-1.83). Neonatal complications were not significantly different comparing fetal scalp electrode with vacuum-assisted vaginal delivery and vacuum-assisted vaginal delivery alone or comparing fetal scalp electrode with forceps-assisted vaginal delivery and forceps-assisted vaginal delivery alone.
We found increased neonatal morbidity with fetal scalp electrode though the absolute risk was very low. It is possible that these findings reflect an underlying indication for its use. Our findings support the use of fetal scalp electrodes when clinically indicated.
Neonatal risks associated with fetal scalp electrode use were low (injury to scalp 1.2% and cephalohaematoma 1.0%).
评估胎儿头皮电极相关并发症的发生率和风险,并确定其在阴道分娩中的应用是否与新生儿发病率增加有关。
回顾性队列研究。
美国 9 个美国妇产科医师学会(ACOG)区域的 19 家医院的 12 个临床中心。
美国妇女。
我们在 2002 年至 2008 年期间对安全分娩联合会研究进行了二次分析,排除了前置剖宫产等妨碍胎儿头皮电极应用的情况后,评估了 171698 名胎龄≥23 周的单胎分娩妇女。还对胎龄≥34 周的阴道分娩进行了二次分析。
计算新生儿并发症的发生率和调整后的比值比及其 95%置信区间,控制了产妇特征、分娩方式和妊娠并发症。
胎儿头皮电极在 37492 例(22%)分娩中使用。在非阴道分娩中,胎儿头皮电极与因分娩创伤导致的头皮损伤风险增加有关(1.2%比 0.9%;调整后的比值比 1.62;95%置信区间 1.41-1.86)和头颅血肿(1.0%比 0.9%;调整后的比值比 1.57;95%置信区间 1.36-1.83)。与真空辅助阴道分娩和单纯真空辅助阴道分娩相比,与头皮电极相比,新生儿并发症无显著差异,与产钳辅助阴道分娩和单纯产钳辅助阴道分娩相比也是如此。
我们发现使用胎儿头皮电极会增加新生儿发病率,但绝对风险非常低。这些发现可能反映了其使用的潜在指征。我们的研究结果支持在临床需要时使用胎儿头皮电极。
使用胎儿头皮电极相关的新生儿风险较低(头皮损伤 1.2%,头颅血肿 1.0%)。